Tuesday, September 18, 2018 7:26:24 AM
I noted the following in a response on 8/23/18:
¨It takes a while and as noted, we are not talking about a huge staff. Doing the statistical analyses is easy, mostly automate after it has been entered (in itself not so easy), the rest is not.¨
Apparently it takes much longer than LE advised we loyal investors´ of ctix/ipix. Regarding p2b, they´ve gone from 3q17 to 4q17 to 1q18 to 1st half 18, to 9/30/18. Anyone who´s not a wee bit taken aback and upset is dishonest imo. It implies he doesn´t know what he´s talking about, while his words have killed most investors.
Regarding another ipix venture, oral mucositis, Galera Therapeutics blows ipix out of the water when it comes to execution.
Ph2b OM study:
Galera started 14 months later than ipix and finished 2 months ahead of ipix(ipix was 69% longer)
Galera enrolled 265% more patients than ipix(223 vs 61)
Galera used 281% more sites than ipix(61 vs 16)
Galera received BTD 164 days after primary trial completion vs ipix, 249 days(as of 8/23/18, 275 days as of 9/18/18) and counting.
To be noted as why results may have taken longer for ipix OM results- ipix had 2 primary outcome mesures vs 1 by Galera, ipix had 16 secondary outcome measures vs 7 for Galera, Ipix had zero other outcome measures vs 14 for Galera. I won´t attempt to filter them.
kfc
Bold print reflects time adjustment from original post.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143127818
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM